晚发型视神经脊髓炎谱系病以脊髓炎为主的侵袭性表型
基于中国神经炎性疾病注册队列748例NMOSD患者,比较晚发(≥60岁,131例)与成人起病(18-59岁,617例)的临床特征与预后。晚发组女性比例更低、起病时横贯性脊髓炎比例更高、年复发率更高、残疾进展更快,且以脊髓炎为主的复发是残疾主因。起病年龄≥60岁是复发、残疾和视力下降的独立危险因素。
要点
- 晚发NMOSD起病时横贯性脊髓炎比例更高,复发以脊髓炎为主。
- 晚发组年复发率与残疾评分均高于成人起病组。
- 起病年龄≥60岁为复发与残疾的独立危险因素。
核心结论
- LO-NMOSD以脊髓炎为主、反复脊髓受累、高复发风险和严重残疾为特征,需加强临床关注并兼顾老年患者安全与疗效的严密监测。
研究设计与样本
- 基于中国神经炎性疾病注册队列748例按2015年国际NMO诊断标准诊断的NMOSD患者,分为成人起病组617例(18-59岁)与晚发组131例(≥60岁),比较人口学、临床、影像、治疗与结局。
主要发现
- 晚发组女性占比76.34%低于成人起病组86.55%,起病时横贯性脊髓炎比例57.36%高于40.17%。
- 晚发组年复发率0.52±0.03高于成人起病组0.38±0.01,中位EDSS 4.75高于3.0。
- 以脊髓炎为主的复发在晚发组为39/45(86.67%),成人起病组为96/148(64.86%),是残疾的重要来源。
- Kaplan-Meier分析显示晚发组复发风险HR=1.932(95%CI 1.427-2.615)、残疾HR=3.192(95%CI 1.932-5.274)、视力≤20/30 HR=3.523(95%CI 1.585-7.828)。
- Cox回归证实起病年龄≥60岁为复发(HR=2.05,95%CI 1.60-2.59)、残疾(HR=3.16,95%CI 2.14-4.62)和视力≤20/30(HR=3.26,95%CI 1.83-5.48)的独立危险因素。
关键数值与推荐
- NMOSD诊断依据2015年国际NMO诊断小组标准。
- 晚发定义:起病年龄≥60岁;成人起病定义:起病年龄18-59岁。
临床怎么用
- 对≥60岁起病的NMOSD患者应提高警惕,重点监测脊髓炎复发并尽早评估残疾进展。
- 老年NMOSD治疗需在严密监测下平衡疗效与安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to compare clinical features and prognosis of late-onset neuromyelitis optica spectrum disorder (LO-NMOSD, onset age ≥60 years) with adult-onset NMOSD (AO-NMOSD, onset age 18-59 years), and to provide insights for individualized management in elderly patients. METHODS: Data from 748 patients with NMOSD (diagnosed according to the 2015 International Panel for NMO Diagnosis criteria) in the China National Registry of Neuro-Inflammatory Diseases (CNRID) were analyzed. Patients were stratified into AO-NMOSD (18-59 years, n = 617) and LO-NMOSD (≥ 60 years, n = 131). Demographics, clinical manifestations, imaging, treatments, and outcomes were compared using appropriate statistical methods including Kaplan-Meier survival curves and Cox proportional hazards regression. RESULTS: LO-NMOSD showed distinct traits: a lower female predominance (76.34% vs 86.55%), higher transverse myelitis (TM) incidence at onset (57.36% vs 40.17%), elevated annualized relapse rate (ARR; 0.52 ± 0.03 vs 0.38 ± 0.01), and accelerated disability (median Expanded Disability Status Scale [EDSS] 4.75 vs 3.0). TM-predominant relapses (39 of 45, 86.67% in LO vs 96 of 148, 64.86% in AO) contributed significantly to disability. Kaplan-Meier analysis showed LO-NMOSD had a higher risk of relapse (hazard ratio [HR] = 1.932, 95% confidence interval [CI] = 1.427-2.615), disability (HR = 3.192, 95% CI = 1.932-5.274) and reaching visual acuity (VA) ≤20 of 30 (HR = 3.523, 95% CI = 1.585-7.828). Cox regression confirmed that onset age ≥60 years was an independent risk factor for relapse (HR = 2.05, 95% CI = 1.60-2.59), disability (HR = 3.16, 95% CI = 2.14-4.62), and reaching VA ≤20 of 30 (HR 3.26, 95% CI = 1.83-5.48). INTERPRETATION: LO-NMOSD is characterized by myelitis-predominance with recurrent spinal cord involvement, high risk of relapses, and severe disability. It thus underscores the need for heightened clinical attention, with rigorous monitoring that balance safety and efficacy for elderly patients with NMOSD. ANN NEUROL 2026;99:1139-1151.
引用
- Pu YL, Feng JZ, Meng HX, et al. Myelitis-Predominant Aggressive Phenotype: Unveiling Unique Patterns of Late-Onset Neuromyelitis Optica Spectrum Disorders. Ann Neurol. 2026. PMID: 41510886. doi:10.1002/ana.78146
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。